All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
|
NHLBI in the Press
Two studies partly funded by NHLBI have shown remarkable results in the treatment of patients with cystic fibrosis who also have at least one copy of the Phe508del CFTR, the most common CF-causing mutation.
|
NHLBI in the Press
Researchers have struggled to capture how mitochondrial DNA escapes the mitochondria—the energy powerhouse—in living cells. But now, a study published in the journal Science, provides an understanding of this process and could explain how inflammation occurs in autoimmune diseases.
|
NHLBI in the Press
Researchers are reporting discovery of a previously unidentified autoinflammatory disorder that triggers mysterious fevers every few weeks. They found that the disorder involves mutations in the RIPK1 gene, which makes a key protein in the mediation of cell death and inflammation.
|
NHLBI in the Press
The latest study conducted by NHLBI’s Prevention and Early Treatment of Acute Lung Injury (PETAL) Network concluded that administering high doses of vitamin D does not reduce mortality or morbidity in critically ill patients with vitamin D deficiencies.